iShares Biotechnology ETF $IBB Shares Newly Purchased by Virtue Capital Management LLC

Virtue Capital Management LLC purchased a new stake in iShares Biotechnology ETF (NASDAQ:IBB) during the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm purchased 13,922 shares of the financial services provider’s stock, valued at approximately $2,931,000.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Bank of America Corp DE lifted its position in shares of iShares Biotechnology ETF by 10.8% during the 1st quarter. Bank of America Corp DE now owns 7,259,501 shares of the financial services provider’s stock worth $1,225,767,000 after purchasing an additional 707,343 shares during the last quarter. Henshaw Capital LLC bought a new stake in iShares Biotechnology ETF during the 1st quarter valued at approximately $20,262,000. MinichMacGregor Wealth Management LLC boosted its stake in iShares Biotechnology ETF by 3,323.4% during the 3rd quarter. MinichMacGregor Wealth Management LLC now owns 78,396 shares of the financial services provider’s stock valued at $16,505,000 after purchasing an additional 76,106 shares during the period. Redstone Wealth Management LLC bought a new stake in iShares Biotechnology ETF during the 3rd quarter valued at approximately $12,401,000. Finally, The Manufacturers Life Insurance Company grew its holdings in iShares Biotechnology ETF by 64.0% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 101,838 shares of the financial services provider’s stock valued at $19,369,000 after buying an additional 39,760 shares during the last quarter. 62.45% of the stock is owned by institutional investors and hedge funds.

iShares Biotechnology ETF Price Performance

Shares of NASDAQ IBB opened at $217.61 on Monday. The business’s 50 day moving average is $208.43 and its two-hundred day moving average is $184.81. iShares Biotechnology ETF has a 12 month low of $154.62 and a 12 month high of $222.29.

iShares Biotechnology ETF Cuts Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, September 18th. Stockholders of record on Tuesday, September 15th were given a $0.0112 dividend. This is a negative change from iShares Biotechnology ETF’s previous quarterly dividend of $0.0238. This represents a $0.04 annualized dividend and a dividend yield of 0.0%. The ex-dividend date of this dividend was Tuesday, September 15th.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.